In a subsequent, more extensive analysis of this topic, the authors found that in basal-like cancers and/or in integrative cluster 10 tumors (basal-like with genomic instablility) TP53 wild type status was positively associated with T-cell activation and a good prognosis [21]. Here, TP53 is linked to cancer.